Ethanol-amine Oleate Sclerotherapy Injection ( DrugBank: Ethanol )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion | 1 |
279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
Clinical trials : 14 / Drugs : 24 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 105
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04930952 (ClinicalTrials.gov) | February 28, 2019 | 11/6/2021 | Complications of Ethanol-amine Oleate Intralesional Sclerotherapy | Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients | Venous Malformation | Drug: Ethanol-amine Oleate Sclerotherapy Injection | Suez Canal University | NULL | Completed | N/A | 12 Years | All | 15 | Egypt |